Therefore, there is evidence supporting the conclusion that H19 acts as an oncogene in thyroid cancer, at least in part via activation of the PI3K/AKT pathway, in order to enhance the pro-survival properties of thyroid cancer cells. The gene discussed is AKT1; the disease is thyroid gland carcinoma.